cbdMD's Broad Spectrum Hemp Extract Reduces Pain In Healthy Adults, Clinical Study Inital Results Confirm
cbdMD, Inc. (AMEX:YCBD) announced the first results from its recently concluded human clinical trial conducted at the University of South Carolina. These studies began in the fall of 2020 and the first results to be reported show the company's proprietary broad spectrum hemp extract reduces pain in healthy adults.
